Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy.

[1]  Deepak L. Bhatt,et al.  One-year cardiovascular event rates in outpatients with atherothrombosis. , 2007, JAMA.

[2]  Deepak L. Bhatt,et al.  The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. , 2006, Journal of the American College of Cardiology.

[3]  J. Grimshaw,et al.  A randomized trial to assess the impact of opinion leader endorsed evidence summaries on the use of secondary prevention strategies in patients with coronary artery disease : the ESP-CAD trial protocol [ NCT 00175240 ] , 2006 .

[4]  Á. Avezum,et al.  Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). , 2006, American heart journal.

[5]  Rodney A. White,et al.  ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Ang , 2006, Journal of the American College of Cardiology.

[6]  R. Califf,et al.  Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease , 2006, Circulation.

[7]  Deepak L. Bhatt,et al.  International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. , 2006, JAMA.

[8]  P. Greenland,et al.  Atherosclerotic Risk Factors Are Less Intensively Treated in Patients with Peripheral Arterial Disease Than in Patients with Coronary Artery Disease , 1997, Journal of General Internal Medicine.

[9]  F. McAlister,et al.  Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary. , 2005, The Canadian journal of cardiology.

[10]  B. Gersh,et al.  Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents. , 2004, Mayo Clinic proceedings.

[11]  D. Malenka,et al.  Survival in patients with peripheral vascular disease after percutaneous coronary intervention and coronary artery bypass graft surgery. , 2004, The Annals of thoracic surgery.

[12]  G. Stone,et al.  Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions. , 2004, The American journal of cardiology.

[13]  J. Knottnerus,et al.  Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study. , 2004, Journal of clinical epidemiology.

[14]  G. Stone,et al.  Impact of Symptomatic Peripheral Arterial Disease on 1-Year Mortality in Patients Undergoing Percutaneous Coronary Interventions , 2004, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[15]  K. Eagle,et al.  Long-term prognostic implication of extracardiac vascular disease in patients undergoing percutaneous coronary intervention. , 2003, The American journal of cardiology.

[16]  E. Topol,et al.  Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization. , 2003, The American journal of cardiology.

[17]  Eric J Topol,et al.  Critical issues in peripheral arterial disease detection and management: a call to action. , 2003, Archives of internal medicine.

[18]  B. Lewis,et al.  Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 stu , 2003, American heart journal.

[19]  Sankey V. Williams,et al.  ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Circulation.

[20]  R. Gibbons.  ACC/AHA guideline for management of patients with chronic stable angina , 2003 .

[21]  E. Laakkonen,et al.  Peripheral Vascular Disease as Predictor of Outcome after Coronary Artery Bypass Grafting , 2002, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

[22]  R. Brant,et al.  Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. , 2001, JAMA.

[23]  M. Criqui,et al.  Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care , 2001 .

[24]  W. Ghali,et al.  Overview of the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease. On behalf of the APPROACH investigators. , 2000, The Canadian journal of cardiology.

[25]  M. A. Sellers,et al.  Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). , 1999, Journal of the American College of Cardiology.

[26]  H. Schaff,et al.  Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation. , 1999, Circulation.

[27]  N. Powe,et al.  Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[28]  M. A. Sellers,et al.  Long-term prognostic value of clinically evident noncoronary vascular disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). , 1998, The American journal of cardiology.

[29]  L. Kuller,et al.  Mortality over Four Years in SHEP Participants with a Low Ankle‐Arm Index , 1997, Journal of the American Geriatrics Society.

[30]  S. Flocke,et al.  Intermittent claudication in 8343 men and 21-year specific mortality follow-up. , 1997, Annals of epidemiology.

[31]  A. Lee,et al.  Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study , 1996, BMJ.

[32]  J. Coresh,et al.  Adjusting survival curves for confounders: a review and a new method. , 1996, American journal of epidemiology.

[33]  J. Birkmeyer,et al.  The effect of peripheral vascular disease on long-term mortality after coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. , 1996, Archives of surgery.

[34]  M. Kornitzer,et al.  Ankle/Arm Pressure Index in Asymptomatic Middle-Aged Males: An Independent Predictor of Ten-Year Coronary Heart Disease Mortality , 1995, Angiology.

[35]  J. Birkmeyer,et al.  The effect of peripheral vascular disease on in-hospital mortality rates with coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. , 1995, Journal of vascular surgery.

[36]  B. Gersh,et al.  Surgical therapy for coronary artery disease among patients with combined coronary artery and peripheral vascular disease. , 1995, Circulation.

[37]  B. Gersh,et al.  Long-term survival in patients with coronary artery disease: Importance of peripheral vascular disease , 1994 .

[38]  L. Kuller,et al.  Decreased ankle/arm blood pressure index and mortality in elderly women. , 1993, JAMA.

[39]  L. Kuller,et al.  Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. , 1993, JAMA.

[40]  J. Hallett.  β-Adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease: Radack K, Deck C. Arch Intern Med 1991;151:1769–1776 , 1993 .

[41]  J. Ricco.  Intermittent claudication, heart disease risk factors, and mortality: Smith GD, Shipley MJ, Rose G. Circulation 1990;82: 1925–1931 , 1992 .

[42]  R. Langer,et al.  Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.

[43]  K. Radack,et al.  Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. , 1991, Archives of internal medicine.

[44]  L. Kuller,et al.  The ratio of ankle and arm arterial pressure as an independent predictor of mortality. , 1991, Atherosclerosis.

[45]  G. Dagenais,et al.  Intermittent claudication in Quebec men from 1974-1986: the Quebec Cardiovascular Study. , 1991, Clinical and investigative medicine. Medecine clinique et experimentale.

[46]  M J Shipley,et al.  Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. , 1990, Circulation.

[47]  E. Varnauskas.  Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. , 1988, The New England journal of medicine.